Banks - Regional
Compare Stocks
2 / 10Stock Comparison
BSBR vs BMA
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
BSBR vs BMA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Banks - Regional | Banks - Regional |
| Market Cap | $43.40B | $4.70B |
| Revenue (TTM) | $151.54B | $6.46T |
| Net Income (TTM) | $12.69B | $291.41B |
| Gross Margin | 27.5% | 68.3% |
| Operating Margin | 11.0% | 5.6% |
| Forward P/E | 6.5x | 0.0x |
| Total Debt | $129.96B | $465.41B |
| Cash & Equiv. | $201.98B | $2.78T |
BSBR vs BMA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Banco Santander (Br… (BSBR) | 100 | 128.8 | +28.8% |
| Banco Macro S.A. (BMA) | 100 | 436.3 | +336.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BSBR vs BMA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BSBR carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 2 yrs, beta 1.11, yield 6.0%
- Rev growth 17.5%, EPS growth 87.4%
- 103.4% 10Y total return vs BMA's 48.5%
BMA is the clearest fit if your priority is defensive and bank quality.
- Beta 1.76, yield 7.0%, current ratio 0.51x
- NIM 11.1% vs BSBR's 4.5%
- Lower P/E (0.0x vs 6.5x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 17.5% NII/revenue growth vs BMA's -33.3% | |
| Value | Lower P/E (0.0x vs 6.5x) | |
| Quality / Margins | Efficiency ratio 0.2% vs BMA's 0.6% (lower = leaner) | |
| Stability / Safety | Beta 1.11 vs BMA's 1.76 | |
| Dividends | 7.0% yield, 1-year raise streak, vs BSBR's 6.0% | |
| Momentum (1Y) | +24.0% vs BMA's -9.1% | |
| Efficiency (ROA) | Efficiency ratio 0.2% vs BMA's 0.6% |
BSBR vs BMA — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
BSBR leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
BMA is the larger business by revenue, generating $6.46T annually — 42.7x BSBR's $151.5B. Profitability is closely matched — net margins range from 8.4% (BSBR) to 5.0% (BMA).
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $151.5B | $6.46T |
| EBITDAEarnings before interest/tax | $18.5B | $620.9B |
| Net IncomeAfter-tax profit | $12.7B | $291.4B |
| Free Cash FlowCash after capex | $5.5B | -$2.44T |
| Gross MarginGross profit ÷ Revenue | +27.5% | +68.3% |
| Operating MarginEBIT ÷ Revenue | +11.0% | +5.6% |
| Net MarginNet income ÷ Revenue | +8.4% | +5.0% |
| FCF MarginFCF ÷ Revenue | +0.9% | +12.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -37.3% | -136.4% |
Valuation Metrics
Evenly matched — BSBR and BMA each lead in 3 of 6 comparable metrics.
Valuation Metrics
At 17.6x trailing earnings, BSBR trades at a 14% valuation discount to BMA's 20.4x P/E. On an enterprise value basis, BSBR's 7.4x EV/EBITDA is more attractive than BMA's 8.5x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $43.4B | $4.7B |
| Enterprise ValueMkt cap + debt − cash | $28.9B | $3.0B |
| Trailing P/EPrice ÷ TTM EPS | 17.60x | 20.42x |
| Forward P/EPrice ÷ next-FY EPS est. | 6.48x | 0.01x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.40x |
| EV / EBITDAEnterprise value multiple | 7.38x | 8.47x |
| Price / SalesMarket cap ÷ Revenue | 1.42x | 1.01x |
| Price / BookPrice ÷ Book value/share | 0.86x | 1.64x |
| Price / FCFMarket cap ÷ FCF | 160.80x | 8.22x |
Profitability & Efficiency
BMA leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
BSBR delivers a 10.2% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $6 for BMA. BMA carries lower financial leverage with a 0.11x debt-to-equity ratio, signaling a more conservative balance sheet compared to BSBR's 1.03x. On the Piotroski fundamental quality scale (0–9), BMA scores 6/9 vs BSBR's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +10.2% | +6.1% |
| ROA (TTM)Return on assets | +1.0% | +1.4% |
| ROICReturn on invested capital | +4.9% | +5.5% |
| ROCEReturn on capital employed | +3.7% | +5.5% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 |
| Debt / EquityFinancial leverage | 1.03x | 0.11x |
| Net DebtTotal debt minus cash | -$72.0B | -$2.31T |
| Cash & Equiv.Liquid assets | $202.0B | $2.78T |
| Total DebtShort + long-term debt | $130.0B | $465.4B |
| Interest CoverageEBIT ÷ Interest expense | 0.16x | 0.28x |
Total Returns (Dividends Reinvested)
Evenly matched — BSBR and BMA each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BMA five years ago would be worth $62,073 today (with dividends reinvested), compared to $10,906 for BSBR. Over the past 12 months, BSBR leads with a +24.0% total return vs BMA's -9.1%. The 3-year compound annual growth rate (CAGR) favors BMA at 69.4% vs BSBR's 5.9% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -3.4% | -13.9% |
| 1-Year ReturnPast 12 months | +24.0% | -9.1% |
| 3-Year ReturnCumulative with dividends | +18.9% | +386.0% |
| 5-Year ReturnCumulative with dividends | +9.1% | +520.7% |
| 10-Year ReturnCumulative with dividends | +103.4% | +48.5% |
| CAGR (3Y)Annualised 3-year return | +5.9% | +69.4% |
Risk & Volatility
BSBR leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
BSBR is the less volatile stock with a 1.11 beta — it tends to amplify market swings less than BMA's 1.76 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BSBR currently trades 79.2% from its 52-week high vs BMA's 70.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.11x | 1.76x |
| 52-Week HighHighest price in past year | $7.32 | $106.15 |
| 52-Week LowLowest price in past year | $4.62 | $38.30 |
| % of 52W HighCurrent price vs 52-week peak | +79.2% | +70.5% |
| RSI (14)Momentum oscillator 0–100 | 48.3 | 53.1 |
| Avg Volume (50D)Average daily shares traded | 968K | 366K |
Analyst Outlook
Evenly matched — BSBR and BMA each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates BSBR as "Buy" and BMA as "Buy". Consensus price targets imply 73.6% upside for BMA (target: $130) vs 24.2% for BSBR (target: $7). For income investors, BMA offers the higher dividend yield at 7.02% vs BSBR's 5.95%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $7.20 | $130.00 |
| # AnalystsCovering analysts | 11 | 14 |
| Dividend YieldAnnual dividend ÷ price | +6.0% | +7.0% |
| Dividend StreakConsecutive years of raises | 2 | 1 |
| Dividend / ShareAnnual DPS | $1.71 | $7302.65 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
BSBR leads in 2 of 6 categories (Income & Cash Flow, Risk & Volatility). BMA leads in 1 (Profitability & Efficiency). 3 tied.
BSBR vs BMA: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is BSBR or BMA a better buy right now?
For growth investors, Banco Santander (Brasil) S.
A. (BSBR) is the stronger pick with 17. 5% revenue growth year-over-year, versus -33. 3% for Banco Macro S. A. (BMA). Banco Santander (Brasil) S. A. (BSBR) offers the better valuation at 17. 6x trailing P/E (6. 5x forward), making it the more compelling value choice. Analysts rate Banco Santander (Brasil) S. A. (BSBR) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BSBR or BMA?
On trailing P/E, Banco Santander (Brasil) S.
A. (BSBR) is the cheapest at 17. 6x versus Banco Macro S. A. at 20. 4x. On forward P/E, Banco Macro S. A. is actually cheaper at 0. 0x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — BSBR or BMA?
Over the past 5 years, Banco Macro S.
A. (BMA) delivered a total return of +520. 7%, compared to +9. 1% for Banco Santander (Brasil) S. A. (BSBR). Over 10 years, the gap is even starker: BSBR returned +103. 4% versus BMA's +48. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BSBR or BMA?
By beta (market sensitivity over 5 years), Banco Santander (Brasil) S.
A. (BSBR) is the lower-risk stock at 1. 11β versus Banco Macro S. A. 's 1. 76β — meaning BMA is approximately 57% more volatile than BSBR relative to the S&P 500. On balance sheet safety, Banco Macro S. A. (BMA) carries a lower debt/equity ratio of 11% versus 103% for Banco Santander (Brasil) S. A. — giving it more financial flexibility in a downturn.
05Which is growing faster — BSBR or BMA?
By revenue growth (latest reported year), Banco Santander (Brasil) S.
A. (BSBR) is pulling ahead at 17. 5% versus -33. 3% for Banco Macro S. A. (BMA). On earnings-per-share growth, the picture is similar: Banco Santander (Brasil) S. A. grew EPS 87. 4% year-over-year, compared to -44. 6% for Banco Macro S. A.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BSBR or BMA?
Banco Santander (Brasil) S.
A. (BSBR) is the more profitable company, earning 8. 4% net margin versus 5. 0% for Banco Macro S. A. — meaning it keeps 8. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BSBR leads at 11. 0% versus 5. 6% for BMA. At the gross margin level — before operating expenses — BMA leads at 68. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BSBR or BMA more undervalued right now?
On forward earnings alone, Banco Macro S.
A. (BMA) trades at 0. 0x forward P/E versus 6. 5x for Banco Santander (Brasil) S. A. — 6. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BMA: 73. 6% to $130. 00.
08Which pays a better dividend — BSBR or BMA?
All stocks in this comparison pay dividends.
Banco Macro S. A. (BMA) offers the highest yield at 7. 0%, versus 6. 0% for Banco Santander (Brasil) S. A. (BSBR).
09Is BSBR or BMA better for a retirement portfolio?
For long-horizon retirement investors, Banco Santander (Brasil) S.
A. (BSBR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 11), 6. 0% yield, +103. 4% 10Y return). Banco Macro S. A. (BMA) carries a higher beta of 1. 76 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BSBR: +103. 4%, BMA: +48. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BSBR and BMA?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: BSBR is a mid-cap high-growth stock; BMA is a small-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.